Drug Story: Ivermectin
The podcast episode discusses the history and impact of ivermectin, a drug that has gained notoriety during the COVID era. It explores its journey from a Nobel Prize-winning anti-parasitic treatment to a controversial figure in medical discussions. The narrative highlights the intersection of medicine, politics, and misinformation surrounding the drug.
- ▪The episode is part of the independent documentary podcast 'Drug Story' hosted by Thomas Goetz.
- ▪Ivermectin is examined as a drug that has transitioned from a medical breakthrough to a polarizing topic.
- ▪The story covers its historical use against hookworm outbreaks and river blindness, as well as its modern implications.
99% Invisible files mainly under podcasts. We currently carry 6 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | 99% Invisible |
| Canonical URL | https://99percentinvisible.org/?p=48072 |
| Publication time | Tue, 26 May 2026 09:00:00 +0000 |
| Retrieval time | 2026-05-26T09:07:47.290Z |
| Last seen | 2026-05-26T09:07:56.384Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | puPPR7pn5Q1y |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Episode 668 Drug Story: Ivermectin PlayPause Click to enlarge image Objects Category Objects Date 05.26.26 Producer 99PI Add to QueueRemove from QueueDownloadTranscript Share on Facebook Share on Twitter Leave a Comment Drug Story is an independent documentary podcast from journalist Thomas Goetz that explores the hidden history of medicine one drug at a time. Each episode uses a single medication to examine the science, politics, culture, and human stories surrounding disease and treatment. And they are SO good. This week, we’re featuring one of their episodes about ivermectin, from Nobel Prize-winning anti-parasitic breakthrough to one of the most polarizing drugs of the COVID era.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at 99% Invisible.
